GSK
Merger confirmed
A new market leader in a range of OTC healthcare categories has been announced Pharmaceutical giants Pfizer and GSK have confirmed they have closed the transaction to create a new …
Deserving the recognition
Ego, GSK win pharmacy nominated honours at industry awards night Ego Pharmaceuticals and GSK were among the honours at the 2018 ASMI (Australian Self-Medication Industry) Awards, held in Sydney recently. …
ACCC alleges misleading representation over Voltaren pain relief gels
GSK says it’s disappointed after the ACCC announced it was taking it and Novartis to court over alleged misleading representations The ACCC announced that it has instituted proceedings in the …
The science of shopping
Pharma giant unveils new retail research lab that aims to give insights into shopper behaviour GlaxoSmithKline (GSK) Consumer Healthcare has unveiled a new Shopper Science Lab in Singapore. A cutting-edge research …
First new asthma treatment in a decade
There is new hope for those with “difficult to treat” asthma in the new year, with breakthrough biologic to be PBS listed on 1 Jan Nucala (mepolizumab) is the first …
Pressure mounts for lower vaccine prices
Last month, Médecins Sans Frontières (MSF) surprised Pfizer by refusing a donation of one million doses of the company’s pneumonia vaccine With high numbers of children who are not immunised against …
GSK is API’s Supplier of the Year
Australian Pharmaceutical Industries Limited has named GSK as Supplier of the Year, at API’s annual Supplier Excellence Awards in Melbourne. API’s CEO and MD, Stephen Roche, said that GSK’s continuous …
GSK in the clear
Panadol Osteo pricing statement ambiguous, but not false or misleading: ACCC The Australian Competition and Consumer Commission has concluded its investigation into whether GlaxoSmithKline (GSK) made misleading statements about a …
NPS MedicineWise rejects ‘selling out’ to big pharma claim
The not-for-profit vehemently denies claims by leading medical publication that it has “sold its soul to big pharma” CEO Dr Lynn Weekes has written a lengthy letter hitting back at …
GSK tops Fortune list of world-changing companies
The pharmaceutical giant was ranked first for its “unmatched record for balancing scientific progress, social impact and the profit motive” Fortune magazine and a panel of experts recently named GlaxoSmithKline the …
Hayfever impact underestimated
The impact of hayfever on quality of life is often underestimated, says one expert. Dr Mimi Tang, allergy specialist at the Murdoch Children’s Research Institute, told the AJP that even …
Patent dispute over generic paracetamol on hold
Initial claims have been dismissed, but there is an opportunity to make further submissions on both sides GlaxoSmithKline’s legal proceeding against Apotex and Generic Partners over its paracetamol products has …